These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9209248)

  • 1. Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation.
    Tallgren M; Olkkola KT; Seppälä T; Höckerstedt K; Lindgren L
    Clin Pharmacol Ther; 1997 Jun; 61(6):655-61. PubMed ID: 9209248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked variation in oxycodone pharmacokinetics in infants.
    Pokela ML; Anttila E; Seppälä T; Olkkola KT
    Paediatr Anaesth; 2005 Jul; 15(7):560-5. PubMed ID: 15960639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers.
    Liukas A; Hagelberg NM; Kuusniemi K; Neuvonen PJ; Olkkola KT
    J Clin Psychopharmacol; 2011 Jun; 31(3):302-8. PubMed ID: 21508859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
    Chan S; Edwards SR; Wyse BD; Smith MT
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation.
    Kirvela M; Lindgren L; Seppala T; Olkkola KT
    J Clin Anesth; 1996 Feb; 8(1):13-8. PubMed ID: 8695073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
    Heiskanen T; Olkkola KT; Kalso E
    Clin Pharmacol Ther; 1998 Dec; 64(6):603-11. PubMed ID: 9871425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
    Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
    Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
    Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
    Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
    Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
    Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of high-dose oxycodone infusion during and after coronary artery bypass grafting.
    Pöyhiä R; Hynynen M; Seppälä T; Roine RO; Verkkala K; Olkkola KT
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):748-54. PubMed ID: 15650985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.
    Lalovic B; Kharasch E; Hoffer C; Risler L; Liu-Chen LY; Shen DD
    Clin Pharmacol Ther; 2006 May; 79(5):461-79. PubMed ID: 16678548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects and plasma concentrations of opioids between elderly and middle-aged patients after cardiac surgery.
    Pesonen A; Suojaranta-Ylinen R; Hammarén E; Tarkkila P; Seppälä T; Rosenberg PH
    Acta Anaesthesiol Scand; 2009 Jan; 53(1):101-8. PubMed ID: 19032559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
    Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH
    Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in renal function in patients with severe hepatitis and liver cancer with cirrhosis during orthotopic liver transplantation].
    Li XY; Hei ZQ; Li SR; Shen N
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):386-9. PubMed ID: 17631701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions.
    Leuppi-Taegtmeyer A; Duthaler U; Hammann F; Schmid Y; Dickenmann M; Amico P; Jehle AW; Kalbermatter S; Lenherr C; Meyer Zu Schwabedissen HE; Haschke M; Liechti ME; Krähenbühl S
    Nephrol Dial Transplant; 2019 Apr; 34(4):692-702. PubMed ID: 30189012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine.
    Kokki M; Heikkinen M; Välitalo P; Hautajärvi H; Hokkanen J; Pitkänen H; Sankilampi U; Ranta VP; Kokki H
    Br J Clin Pharmacol; 2017 Apr; 83(4):791-800. PubMed ID: 27780305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients.
    Naito T; Tashiro M; Ishida T; Ohnishi K; Kawakami J
    J Clin Pharmacol; 2013 Aug; 53(8):812-8. PubMed ID: 23733622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxycodone: new 'old' drug.
    Olkkola KT; Hagelberg NM
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):459-62. PubMed ID: 19369865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fentanyl pharmacokinetics in patients undergoing renal transplantation.
    Koehntop DE; Rodman JH
    Pharmacotherapy; 1997; 17(4):746-52. PubMed ID: 9250552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children.
    Kokki H; Rasanen I; Lasalmi M; Lehtola S; Ranta VP; Vanamo K; Ojanperä I
    Clin Pharmacokinet; 2006; 45(7):745-54. PubMed ID: 16802855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.